RESUMEN

Cannabis is one of the most commonly used recreational drugs worldwide. Rrecent epidemiology studies have linked increased cardiac complications to cannabis use. However, this literature is predominantly based on case incidents and post-mortem investigations. This study elucidates the molecular mechanism of Δ9-tetrahydrocannabinol (THC), and its primary metabolites 11-Hydroxy-Δ9-THC (THC-OH) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH). Treatment of cardiac myocytes with THC-OH and THC-COOH increased cell migration and proliferation (p < 0.05), with no effect on cell adhesion, with higher doses (250-100 ng/mL) resulting in increased cell death and significant deterioration in cellular architecture. Conversely, no changes in cell morphology or viability were observed in response to THC. Expression of key ECM proteins α-SMA and collagen were up-regulated in response to THC-OH and THC-COOH treatments with concomitant modulation of PI3K and MAPK signalling. Investigations in the planarian animal model Polycelis nigra demonstrated that treatments with cannabinoid metabolites resulted in increased protein deposition at transection sites while higher doses resulted in significant lethality and decline in regeneration. These results highlight that the key metabolites of cannabis elicit toxic effects independent of the parent and psychoactive compound, with implications for cardiotoxicity relating to hypertrophy and fibrogenesis.

Asunto(s)

Cannabis , Alucinógenos , Analgésicos/metabolismo , Animales , Agonistas de Receptores de Cannabinoides , Cannabis/metabolismo , Cannabis/toxicidad , Cardiotoxicidad , Dronabinol/toxicidad , Alucinógenos/metabolismo , Miocitos Cardíacos/metabolismo

RESUMEN

The activation of microglia, the inflammatory cells of the central nervous system (CNS), has been linked to the pathogenesis of Alzheimer's disease and other neurodegenerative diseases. How microglia sense the changing brain environment, in order to respond appropriately, is still being elucidated. Microglia are able to sense and respond to the mechanical properties of their microenvironment, and the physical and molecular pathways underlying this mechanosensing/mechanotransduction in microglia have recently been investigated. The Hippo pathway functions through mechanosensing and subsequent protein kinase cascades, and is critical for neuronal development and many other cellular processes. In this review, we examine evidence for the potential involvement of Hippo pathway components specifically in microglia in the pathogenesis of Alzheimer's disease. We suggest that the Hippo pathway is worth investigating as a mechanosensing pathway in microglia, and could be one potential therapeutic target pathway for preventing microglial-induced neurodegeneration in AD.

Asunto(s)

Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología , Vía de Señalización Hippo , Mecanotransducción Celular , Microglía/metabolismo , Microglía/patología , Animales , Humanos , Modelos Biológicos

RESUMEN

In order to ascertain their external environment, cells and tissues have the capability to sense and process a variety of stresses, including stretching and compression forces. These mechanical forces, as experienced by cells and tissues, are then converted into biochemical signals within the cell, leading to a number of cellular mechanisms being activated, including proliferation, differentiation and migration. If the conversion of mechanical cues into biochemical signals is perturbed in any way, then this can be potentially implicated in chronic disease development and processes such as neurological disorders, cancer and obesity. This review will focus on how the interplay between mechanotransduction, cellular structure, metabolism and signalling cascades led by the Hippo-YAP/TAZ axis can lead to a number of chronic diseases and suggest how we can target various pathways in order to design therapeutic targets for these debilitating diseases and conditions.

Asunto(s)

Proteínas de Ciclo Celular/metabolismo , Enfermedad Crónica/epidemiología , Mecanotransducción Celular , Proteínas Serina-Treonina Quinasas/metabolismo , Factores de Transcripción/metabolismo , Aciltransferasas , Vía de Señalización Hippo , Humanos , Transducción de Señal

RESUMEN

Protein misfolding caused by inherited mutations leads to loss of protein function and potentially toxic 'gain of function', such as the dominant P23H rhodopsin mutation that causes retinitis pigmentosa (RP). Here, we tested whether the AMPK activator metformin could affect the P23H rhodopsin synthesis and folding. In cell models, metformin treatment improved P23H rhodopsin folding and traffic. In animal models of P23H RP, metformin treatment successfully enhanced P23H traffic to the rod outer segment, but this led to reduced photoreceptor function and increased photoreceptor cell death. The metformin-rescued P23H rhodopsin was still intrinsically unstable and led to increased structural instability of the rod outer segments. These data suggest that improving the traffic of misfolding rhodopsin mutants is unlikely to be a practical therapy, because of their intrinsic instability and long half-life in the outer segment, but also highlights the potential of altering translation through AMPK to improve protein function in other protein misfolding diseases.

Asunto(s)

Proteínas Quinasas Activadas por AMP/genética , Metformina/administración & dosificación , Degeneración Retiniana/genética , Retinitis Pigmentosa/genética , Rodopsina/genética , Proteínas Quinasas Activadas por AMP/biosíntesis , Animales , Modelos Animales de Enfermedad , Humanos , Ratones , Proteínas Mutantes/genética , Células Fotorreceptoras/efectos de los fármacos , Células Fotorreceptoras/patología , Pliegue de Proteína/efectos de los fármacos , Deficiencias en la Proteostasis/genética , Deficiencias en la Proteostasis/patología , Ratas , Degeneración Retiniana/tratamiento farmacológico , Degeneración Retiniana/patología , Células Fotorreceptoras Retinianas Bastones/efectos de los fármacos , Células Fotorreceptoras Retinianas Bastones/metabolismo , Células Fotorreceptoras Retinianas Bastones/patología , Retinitis Pigmentosa/tratamiento farmacológico , Retinitis Pigmentosa/patología , Rodopsina/química , Segmento Externo de la Célula en Bastón/efectos de los fármacos , Segmento Externo de la Célula en Bastón/patología , Activación Transcripcional/efectos de los fármacos

RESUMEN

The peripheral nervous system has remarkable regenerative capacities in that it can repair a fully cut nerve. This requires Schwann cells to migrate collectively to guide regrowing axons across a 'bridge' of new tissue, which forms to reconnect a severed nerve. Here we show that blood vessels direct the migrating cords of Schwann cells. This multicellular process is initiated by hypoxia, selectively sensed by macrophages within the bridge, which via VEGF-A secretion induce a polarized vasculature that relieves the hypoxia. Schwann cells then use the blood vessels as "tracks" to cross the bridge taking regrowing axons with them. Importantly, disrupting the organization of the newly formed blood vessels in vivo, either by inhibiting the angiogenic signal or by re-orienting them, compromises Schwann cell directionality resulting in defective nerve repair. This study provides important insights into how the choreography of multiple cell-types is required for the regeneration of an adult tissue.

Asunto(s)

Vasos Sanguíneos/metabolismo , Macrófagos/metabolismo , Nervios Periféricos/fisiología , Células de Schwann/metabolismo , Animales , Axones/metabolismo , Hipoxia de la Célula , Células Endoteliales/metabolismo , Inflamación/metabolismo , Masculino , Ratones , Neovascularización Fisiológica , Ratas , Ratas Sprague-Dawley , Regeneración , Factor A de Crecimiento Endotelial Vascular/genética

RESUMEN

Jaw morphogenesis depends on the growth of Meckel's cartilage during embryogenesis. However, the cell types and signals that promote chondrocyte proliferation for Meckel's cartilage growth are poorly defined. Here we show that neural crest cells (NCCs) and their derivatives provide an essential source of the vascular endothelial growth factor (VEGF) to enhance jaw vascularization and stabilize the major mandibular artery. We further show in two independent mouse models that blood vessels promote Meckel's cartilage extension. Coculture experiments of arterial tissue with NCCs or chondrocytes demonstrated that NCC-derived VEGF promotes blood vessel growth and that blood vessels secrete factors to instruct chondrocyte proliferation. Computed tomography and X-ray scans of patients with hemifacial microsomia also showed that jaw hypoplasia correlates with mandibular artery dysgenesis. We conclude that cranial NCCs and their derivatives provide an essential source of VEGF to support blood vessel growth in the developing jaw, which in turn is essential for normal chondrocyte proliferation, and therefore jaw extension.

Asunto(s)

Síndrome de Goldenhar/fisiopatología , Mandíbula/anomalías , Mandíbula/embriología , Cresta Neural/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Adolescente , Animales , Cartílago/embriología , Diferenciación Celular , Proliferación Celular , Condrocitos/metabolismo , Técnicas de Cocultivo , Femenino , Síndrome de Goldenhar/diagnóstico por imagen , Humanos , Hibridación in Situ , Masculino , Mandíbula/irrigación sanguínea , Ratones , Cresta Neural/citología , Tomografía Computarizada por Rayos X , Proteína Wnt1/genética

RESUMEN

We used live imaging by fiber-optic confocal microendoscopy (CME) of yellow fluorescent protein (YFP) expression in motor neurons to observe and monitor axonal and neuromuscular synaptic phenotypes in mutant mice. First, we visualized slow degeneration of axons and motor nerve terminals at neuromuscular junctions following sciatic nerve injury in Wld(S) mice with slow Wallerian degeneration. Protection of axotomized motor nerve terminals was much weaker in Wld(S) heterozygotes than in homozygotes. We then induced covert modifiers of axonal and synaptic degeneration in heterozygous Wld(S) mice, by N-ethyl-N-nitrosourea (ENU) mutagenesis, and used CME to identify candidate mutants that either enhanced or suppressed axonal or synaptic degeneration. From 219 of the F1 progeny of ENU-mutagenized BALB/c mice and thy1.2-YFP16/Wld(S) mice, CME revealed six phenodeviants with suppression of synaptic degeneration. Inheritance of synaptic protection was confirmed in three of these founders, with evidence of Mendelian inheritance of a dominant mutation in one of them (designated CEMOP_S5). We next applied CME repeatedly to living Wld(S) mice and to SOD1(G93A) mice, an animal model of motor neuron disease, and observed degeneration of identified neuromuscular synapses over a 1-4day period in both of these mutant lines. Finally, we used CME to observe slow axonal regeneration in the ENU-mutant ostes mouse strain. The data show that CME can be used to monitor covert axonal and neuromuscular synaptic pathology and, when combined with mutagenesis, to identify genetic modifiers of its progression in vivo.

Asunto(s)

Axones/ultraestructura , Endoscopía/métodos , Tecnología de Fibra Óptica/métodos , Microscopía Confocal/métodos , Proteínas del Tejido Nervioso/metabolismo , Unión Neuromuscular/ultraestructura , Superóxido Dismutasa/metabolismo , Animales , Axones/patología , Axones/fisiología , Modelos Animales de Enfermedad , Femenino , Tecnología de Fibra Óptica/instrumentación , Humanos , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Mutantes , Ratones Transgénicos , Microscopía Confocal/instrumentación , Enfermedad de la Neurona Motora/genética , Enfermedad de la Neurona Motora/metabolismo , Enfermedad de la Neurona Motora/patología , Neuronas Motoras/citología , Neuronas Motoras/metabolismo , Mutación , Regeneración Nerviosa/fisiología , Proteínas del Tejido Nervioso/genética , Unión Neuromuscular/patología , Unión Neuromuscular/fisiología , Fenotipo , Superóxido Dismutasa/genética , Sinapsis/patología , Sinapsis/fisiología , Sinapsis/ultraestructura , Degeneración Walleriana/metabolismo , Degeneración Walleriana/patología

RESUMEN

Following a screen for neuromuscular mouse mutants, we identified ostes, a novel N-ethyl N-nitrosourea-induced mouse mutant with muscle atrophy. Genetic and biochemical evidence shows that upregulation of the novel, uncharacterized transient receptor potential polycystic (TRPP) channel PKD1L2 (polycystic kidney disease gene 1-like 2) underlies this disease. Ostes mice suffer from chronic neuromuscular impairments including neuromuscular junction degeneration, polyneuronal innervation and myopathy. Ectopic expression of PKD1L2 in transgenic mice reproduced the ostes myopathic changes and, indeed, caused severe muscle atrophy in Tg(Pkd1l2)/Tg(Pkd1l2) mice. Moreover, double-heterozygous mice (ostes/+, Tg(Pkd1l2)/0) suffer from myopathic changes more profound than each heterozygote, indicating positive correlation between PKD1L2 levels and disease severity. We show that, in vivo, PKD1L2 primarily associates with endogenous fatty acid synthase in normal skeletal muscle, and these proteins co-localize to costameric regions of the muscle fibre. In diseased ostes/ostes muscle, both proteins are upregulated, and ostes/ostes mice show signs of abnormal lipid metabolism. This work shows the first role for a TRPP channel in neuromuscular integrity and disease.

Asunto(s)

Enfermedades Neuromusculares/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Regulación hacia Arriba , Animales , Células Cultivadas , Modelos Animales de Enfermedad , Ácido Graso Sintasas/genética , Ácido Graso Sintasas/metabolismo , Femenino , Células HeLa , Humanos , Lactante , Masculino , Ratones , Ratones Transgénicos , Músculo Esquelético/metabolismo , Mutación , Enfermedades Neuromusculares/genética , Unión Proteica , Receptores Acoplados a Proteínas G/genética